Cuban President Miguel Díaz-Canel Bermúdez expressed today Cuba's gratitude to the head of the South African state Cyril Ramaphosa’s support for the Henry Reeve Medical Contingent Nobel Peace Prize nomination.

When the COVID-19 is raging and refuses to be banished from Cuba and the world, in recent months the increase of the contagion in pediatric patients on the island has been worrying, something that alerts the medical community and activates efforts, as can be seen today in the province of Guantánamo, the province with the highest incidence rate of the pandemic in the country.

Cuba joins the global community in commemorating World Cancer Day, a disease that, according to the Pan American Health Organization, is the second leading cause of death in the Americas.

The fact that more beds are being prepared for the prevention and control of HIV/AIDS-19 is frightening news, but it also means that the conditions to solve this third outbreak of the pandemic are growing in effectiveness.

The new facilities of the Center for Neurosciences of Cuba (CNEURO), close to the completion of its investment process, will have a large production capacity for the manufacture of swabs used in PCR sampling.

Cuba studied 18,004 samples for COVID 19, resulting in 1,044 positive ones. The country accumulates 1, 922,930 samples taken and 28,636 positive.

One of the four Cuban COVID 19 candidate vaccines has just begun phase 2 of clinical trials in Santiago de Cuba province.

Cuba reported in January 15,536 positive cases of SARS-CoV-2 and 70 deaths from the disease, the highest figures since the outbreak of the epidemic in the country in March last year.

Cuba studied 18,403 samples for COVID-19, resulting in 906 positive ones. The country accumulates 1,904,926 samples taken and 27,592 positive.

The second phase of the clinical trial of the vaccine candidate CIGB 66 (Abdala), one of the four nationally produced against COVID-19, begins this Monday at the Saturnino Lora provincial hospital in Santiago de Cuba.

Conditions are created to try to start the trial with the vaccine candidates Soberana 01 and Soberana 02 in children and teenagers by the end of February, informed Doctor of Science Vicente Vérez Bencomo, general director of the Finlay Vaccine Institute (IFV).

Cuba studied 13,903 samples for COVID-19, resulting in 659 positive ones. The country accumulates 1, 851,950 samples taken and 24,764 positive.

The anti-COVID-19 vaccine candidate CIGB 66, known as Abdala, is advancing to the second phase of the clinical trial, scheduled to begin on February 1 at the Saturnino Lora provincial hospital in Santiago de Cuba.

Cuba reported today 666 new cases of the SARS-CoV-2 and four deaths from the infectious disease, for a total of 24,105 positive cases and 208 deceases.